Cellectar Biosciences (CLRB) Reports Q1 Loss of $0.30/Share
Cellectar Biosciences (NASDAQ: CLRB) reported Q1 EPS of ($0.30), versus ($1.03) reported last year.
For earnings history and earnings-related data on Cellectar Biosciences (CLRB) click here.
